Cargando…
UBE2C triggers HIF‐1α‐glycolytic flux in head and neck squamous cell carcinoma
Head and neck squamous cell carcinoma (HNSCC) is the most common malignancy in Taiwan. Therefore, refining the diagnostic sensitivity of biomarkers for early‐stage tumours and identifying therapeutic targets are critical for improving the survival rate of HNSCC patients. Metabolic reprogramming cont...
Autores principales: | Yang, Yi‐Fang, Chang, Yu‐Chan, Tsai, Kuo‐Wang, Hung, Ming‐Hsin, Kang, Bor‐Hwang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258705/ https://www.ncbi.nlm.nih.gov/pubmed/35615976 http://dx.doi.org/10.1111/jcmm.17400 |
Ejemplares similares
-
UBE2O Promotes Progression and Epithelial–Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma
por: Chen, Xiyu, et al.
Publicado: (2020) -
The Influence of Met Receptor Level on HGF-Induced Glycolytic Reprogramming in Head and Neck Squamous Cell Carcinoma
por: Boschert, Verena, et al.
Publicado: (2020) -
UBE2C is a Potential Biomarker for Tumorigenesis and Prognosis in Tongue Squamous Cell Carcinoma
por: Liu, Pei-Feng, et al.
Publicado: (2020) -
Mediation of PKM2-dependent glycolytic and non-glycolytic pathways by ENO2 in head and neck cancer development
por: Gao, Lixia, et al.
Publicado: (2023) -
Glycolytic flux control by drugging phosphoglycolate phosphatase
por: Jeanclos, Elisabeth, et al.
Publicado: (2022)